NASDAQ:ASTH Astrana Health (ASTH) Stock Price, News & Analysis $35.81 +1.37 (+3.98%) As of 02:46 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Astrana Health Stock (NASDAQ:ASTH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Astrana Health alerts:Sign Up Key Stats Today's Range$34.11▼$36.0950-Day Range$33.55▼$45.4652-Week Range$18.08▼$51.60Volume145,041 shsAverage Volume529,491 shsMarket Capitalization$2.00 billionP/E Ratio43.67Dividend YieldN/APrice Target$49.88Consensus RatingModerate Buy Company Overview Astrana Health, Inc. is a healthcare management and technology company that helps physicians and healthcare organizations deliver value-based care. The company supports provider groups, independent physicians and health systems with clinical, operational and administrative services designed to coordinate care, improve outcomes and manage healthcare costs. Astrana Health’s platform includes care-management programs, analytics and population-health tools, technology solutions, physician practice support, and services for risk-bearing provider organizations. Its model is focused primarily on capitated and other value-based arrangements, in which providers are responsible for coordinating care for defined patient populations. The company serves Medicare and other healthcare populations through affiliated medical groups and provider networks. The company was founded as ApolloMed in 1994 and adopted the Astrana Health name in 2023 as part of a broader effort to reflect its healthcare enablement platform. Astrana Health is headquartered in Los Angeles and primarily operates through provider and healthcare partnerships in the United States, with a significant presence in California and activities in additional markets. Brandon Sim serves as the company’s chief executive officer.AI Generated. May Contain Errors. Read More Astrana Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks79th Percentile Overall ScoreASTH MarketRank™: Astrana Health scored higher than 79% of companies evaluated by MarketBeat, and ranked 79th out of 908 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingAstrana Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on no strong buy ratings, 8 buy ratings, 2 hold ratings, and no sell ratings.Upside PotentialAstrana Health has a consensus price target of $49.88, representing about 39.2% upside from its current price of $35.82.Amount of Analyst CoverageAstrana Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Astrana Health's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth41.91% Earnings GrowthEarnings for Astrana Health are expected to grow by 41.91% in the coming year, from $1.36 to $1.93 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Astrana Health is 43.81, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.94.Price to Earnings Ratio vs. SectorThe P/E ratio of Astrana Health is 43.81, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.69.Price to Book Value per Share RatioAstrana Health has a P/B Ratio of 2.54. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Astrana Health's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.37% of the float of Astrana Health has been sold short.Short Interest Ratio / Days to CoverAstrana Health has a short interest ratio ("days to cover") of 11.71, which indicates bearish sentiment.Change versus previous monthShort interest in Astrana Health has recently decreased by 0.27%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAstrana Health does not currently pay a dividend.Dividend GrowthAstrana Health does not have a long track record of dividend growth. News and Social Media2.1 / 5News Sentiment0.39 News SentimentAstrana Health has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Astrana Health this week, compared to 3 articles on an average week. Company Ownership1.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Astrana Health insiders have not sold or bought any company stock.Percentage Held by Insiders20.30% of the stock of Astrana Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Astrana Health's insider trading history. Receive ASTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Astrana Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ASTH Stock News HeadlinesPRIVACY ALERT: AWKO Law Investigating Astrana Health Data Breach2 hours ago | businesswire.comAstrana Health (NASDAQ:ASTH) Shares Gap Down - Should You Sell?September 25 at 5:21 AM | americanbankingnews.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.September 25 at 1:00 AM | Profits Run (Ad)INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTHSeptember 24 at 4:17 PM | prnewswire.comAstrana is latest U.S. healthcare company to face acyberattackSeptember 23 at 1:27 PM | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTHSeptember 22 at 8:08 PM | globenewswire.comLowey Dannenberg, P.C. is Investigating Astrana Health, Inc. (NASDAQ: ASTH) for Potential Violations of the Federal Securities LawsSeptember 22 at 10:35 AM | globenewswire.comAstrana Health: Strong Execution, Still No Re-RatingSeptember 21, 2026 | seekingalpha.comSee More Headlines ASTH Stock Analysis - Frequently Asked Questions How have ASTH shares performed this year? Astrana Health's stock was trading at $24.81 at the start of the year. Since then, ASTH shares have increased by 44.4% and is now trading at $35.8210. How were Astrana Health's earnings last quarter? Astrana Health, Inc. (NASDAQ:ASTH) issued its earnings results on Thursday, August, 6th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.46. Astrana Health's revenue was up 48.5% on a year-over-year basis. Read the conference call transcript. Who are Astrana Health's major shareholders? Astrana Health's top institutional shareholders include Wellington Management Group LLP (2.32%), Diamond Hill Capital Management LLC Investment Advisor (0.85%), Bank of New York Mellon Corp (0.42%) and California State Teachers Retirement System (0.09%). How do I buy shares of Astrana Health? Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Astrana Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Astrana Health investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX) and Visa (V). Company Calendar Last Earnings8/06/2026Today9/25/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1w+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 For the last 10 days, ASTH's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:ASTH Previous SymbolNASDAQ:ASTH CIK1083446 Webwww.astranahealth.com Phone626-282-0288Fax818-839-5190Employees3,000Year Founded1985Price Target and Rating Average Price Target for Astrana Health$49.88 High Price Target$65.00 Low Price Target$37.00 Potential Upside/Downside+39.2%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)$0.82 Trailing P/E Ratio43.81 Forward P/E Ratio26.34 P/E GrowthN/ANet Income$22.49 million Net Margins1.05% Pretax Margin1.56% Return on Equity10.30% Return on Assets3.67% Debt Debt-to-Equity Ratio1.05 Current Ratio1.23 Quick Ratio1.23 Sales & Book Value Annual Sales$3.18 billion Price / Sales0.63 Cash Flow$2.87 per share Price / Cash Flow12.48 Book Value$14.09 per share Price / Book2.54Miscellaneous Outstanding Shares55,740,000Free Float44,422,000Market Cap$2.00 billion OptionableOptionable Beta0.90 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:ASTH) was last updated on 9/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astrana Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astrana Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
